phorbol-12-myristate has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brouland, JP; Enyedi, A; Hegedűs, L; Padányi, R; Papp, B; Pászty, K; Varga, K | 1 |
Du, JW; Fang, LY; Qi, XL; Xu, KY | 1 |
2 other study(ies) available for phorbol-12-myristate and Breast Neoplasms
Article | Year |
---|---|
Histone deacetylase inhibitor- and PMA-induced upregulation of PMCA4b enhances Ca2+ clearance from MCF-7 breast cancer cells.
Topics: Breast Neoplasms; Calcium; Cell Differentiation; Cell Proliferation; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Maleimides; MCF-7 Cells; Pentanoic Acids; Phorbol Esters; Plasma Membrane Calcium-Transporting ATPases; Protein Isoforms; RNA, Messenger; Up-Regulation; Vorinostat | 2014 |
Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD34; Breast Neoplasms; CD28 Antigens; CD3 Complex; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Interleukin-17; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred BALB C; Microvessels; Neovascularization, Pathologic; Phorbol Esters; Recombinant Proteins | 2012 |